Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $58.1952W HIGH $93.50
Volume
12.72 K
Value Traded
16.21 M
Short % Float
8.94%
Days to Cover
6.9
+2.48%Week
+5.54%1 Month
+16.99%3 Month
+15.23%6 Month
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
1.19 B
EPS (TTM)
2.16
P/E Ratio
40.29
Ent. Value
1.49 B
Total Shares
14.92 M
Float Shares
14.54 M
Insiders
2.57%
Institutions
109.54%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | Small Molecule | Oncology | - |
PoA blends historical approval base rates, trial design score and FDA review track record.
USPH Catalyst Timeline
Dated clinical, regulatory and corporate events for US Physical Therapy Inc
Catalyst Timeline
Dated clinical, regulatory & corporate events for US Physical Therapy Inc
3Total events
0Upcoming
1Tier-1 (high impact)
2026 to 2026Coverage
Past FDA Catalysts and PDUFA Decisions
How USPH actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| - | Example Drug | Phase 3 data readout | Phase 3 |
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
No drug pipeline
US Physical Therapy Inc is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every USPH program
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Minan Peter FrancisDirector | Buy | 5.27 3,217.14 held | $79.00 | 09/11/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in USPH
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| No hedge fund reported a 13F position in USPH for Q2 2026. | ||||
USPH Institutional Ownership Trends
USPH Short Interest
Shares sold short, counted twice a month.
8.94%
Short % of Float
of tradable shares sold short
1.3M
Shares Sold Short
+0.5% vs prior count
6.9 High
Days to Cover
trading days of normal volume to buy every short share back
188.2K
Avg Daily Volume
the average used for days to cover
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How USPH ranks across every disease it competes in
Competitive Position is a premium feature
See how USPH ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialUSPH News
-USPH
Oct 21, 2026▲ +0.3%today
U.S. Physical Therapy, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call Dates
U.S. Physical Therapy, Inc. will release its financial results for Q3 2026 on November 4, 2026. A conference call is set for the following morning, November 5, 2026. This event aims to provide insights into the company's performance and engage with investors.
Read more →-USPH
Sep 21, 2026U.S. Physical Therapy Announces the Appointment of New Board Member Myra Davis
U.S. Physical Therapy, Inc. has announced the appointment of Myra Davis to its Board of Directors, effective October 1, 2026. Davis, who is currently the Executive Vice President and Chief Information Innovation Officer at Texas Children's Hospital, is expected to bring valuable expertise to the company. This move reflects the company's commitment to strengthening its leadership.
Read more →-USPH
Aug 27, 2026U.S. Physical Therapy Presented at the 17th Annual Midwest Ideas Conference
U.S. Physical Therapy, Inc. (USPH) recently participated in the 17th Annual Midwest Ideas Conference, where CEO Chris Reading discussed the company's operational environment and key initiatives. This presentation underscores the company's strategic focus and engagement in the healthcare sector. The event took place on August 26, 2026.
Read more →-USPH
Aug 14, 2026U.S. Physical Therapy Announces CFO
U.S. Physical Therapy has appointed Nchacha Etta as the new Executive Vice President and Chief Financial Officer, effective September 1, 2026. Etta will succeed Jason Curtis, who has been serving as the Interim CFO since April 2026. This leadership change reflects the company's commitment to strong financial management.
Read more →-USPH
Jul 22, 2026U.S. Physical Therapy, Inc. Schedules Second Quarter 2026 Earnings Release and Conference Call Dates
U.S. Physical Therapy, Inc. has announced the dates for its second quarter 2026 earnings release and conference call. The financial results will be reported on August 5, 2026, after market close, followed by a conference call on August 6, 2026. This reflects the company's commitment to keeping stakeholders informed.
Read more →-USPH
Jul 2, 2026U.S. Physical Therapy Announces the Acquisition of a Twelve-Clinic Physical Therapy Practice
U.S. Physical Therapy has announced the acquisition of a twelve-clinic physical therapy practice. This move is part of the company's strategy to expand its footprint in the physical therapy market. Further details about the clinics and financial implications were not disclosed in the announcement.
Read more →-USPH
Jul 2, 2026USPh Announces the Acquisition of a Twelve-Clinic Physical Therapy Practice
U.S. Physical Therapy, Inc. (USPH) has announced the acquisition of a twelve-clinic physical therapy practice, effective July 1, 2026. The company acquired a 67% equity interest, with the remaining 33% retained by the current owners. This acquisition increases USPH's operational presence to 45 states and is expected to enhance patient care and community relationships.
Read more →-USPH
May 14, 2026▲ +8.2%on this news
USPh Presented at the BofA Securities 2026 Healthcare Conference
U.S. Physical Therapy, Inc. presented at the BofA Securities 2026 Healthcare Conference on May 13, 2026. CEO Chris Reading highlighted the operating environment in healthcare, key initiatives, and opportunities for growth. The company manages 784 outpatient clinics nationwide, focusing on orthopedic and neurological rehabilitation.
Read more →-USPH
May 7, 2026▼ -19.9%on this news
U.S. Physical Therapy, Inc. Conference Call Transcript
U.S. Physical Therapy, Inc. recently reported its Q1 2026 financial results, showing a 7.2% increase in revenue from physical therapy services. The company reaffirmed its growth guidance for 2026, crediting ongoing initiatives and partnerships for its optimistic outlook. However, net income has dropped significantly when compared to the previous year, which indicates some financial challenges. The company is expecting to overcome these hurdles through strategic acquisitions and partnerships, particularly in injury prevention and cash-based programs.
Read more →-USPH
May 6, 2026USPh Reports Record First Quarter Revenue, Reaffirms Full Year Guidance
USPh has announced a record revenue for the first quarter of the fiscal year, showcasing strong financial performance. The company has also reaffirmed its guidance for the full year, suggesting confidence in its ongoing operations and market conditions. This positive news reflects the company's growth trajectory and strategic initiatives.
Read more →-USPH
May 6, 2026U.S. Physical Therapy Reports Record First Quarter Revenue, Reaffirms Full Year Guidance
U.S. Physical Therapy, Inc. reported record revenue for the first quarter of 2026, alongside a reaffirmation of its full year guidance for adjusted EBITDA. The CEO highlighted various initiatives aimed at improving patient care and operational efficiency, including new technology implementations and partnerships. The company also reported significant expected EBITDA contributions from its strategic hospital alliances. The overall tone of the report is optimistic regarding future performance.
Read more →-USPH
Apr 22, 2026U.S. Physical Therapy, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call Dates
U.S. Physical Therapy, Inc. has announced the dates for its first quarter 2026 earnings release and conference call. The company is expected to provide financial results and insights during this event. Further details regarding the specifics of the earnings will likely be shared closer to the date.
Read more →-USPH
Apr 15, 2026USPh Announces $450 Million Credit Facility
U.S. Physical Therapy, Inc. (USPH) has announced the closing of a $450 million credit facility, which includes a $175 million term loan and a $275 million revolver. This facility was upsized from an initial $400 million due to strong lender support and extends the maturity date to April 14, 2031. The increased capacity will aid in the growth of USPH's physical therapy and industrial injury prevention businesses.
Read more →-USPH
Apr 15, 2026U.S. Physical Therapy Announces
U.S. Physical Therapy, Inc. announced the closing of a $450 million credit facility, an increase from its initial $400 million. The new facility includes a $175 million term loan and a $275 million revolving credit line, with a maturity date set for April 14, 2031. Company officials indicate that this upsized credit facility reflects strong lender confidence and is expected to support further growth and capital returns to shareholders. Key banking partners include Bank of America and Regions Bank among others.
Read more →-USPH
Mar 12, 2026USPh Presented at the Barclays 28th Annual Global Healthcare Conference
U.S. Physical Therapy, Inc. (USPH) presented at the Barclays 28th Annual Global Healthcare Conference on March 11, 2026. The presentation was led by Chris Reading, the Chairman and CEO of the company. USPH operates 783 outpatient physical therapy clinics across 44 states, providing various services including injury prevention and rehabilitation.
Read more →-USPH
Mar 9, 2026U.S. PHYSICAL THERAPY, INC. 2026 OBJECTIVE LONG-TERM INCENTIVE PLAN FOR SENIOR MANAGEMENT ("Objective LTIP") Purpose : To incentivize and retain Executives eligible for this Objective LTIP, to achieve certain corporate e
U.S. Physical Therapy, Inc. has introduced a new long-term incentive plan for senior management effective March 9, 2026. This plan aims to incentivize and retain key executives by offering them Restricted Stock Units (RSUs) contingent on meeting corporate earnings criteria. The awarded RSUs will vest over time, thereby enhancing the executives' equity interest in the company. The performance criteria for earning these awards will be based on the company's Adjusted EBITDA for the year 2026.
Read more →-USPH
Mar 9, 2026Disclaimer 2 Forward-Looking Statements This presentation contains forward-looking statements, which involve numerous risks and uncertainties. Included among such statements may be those relating to new clinics, availabi
U.S. Physical Therapy, Inc. has issued a presentation highlighting forward-looking statements involving significant risks and uncertainties. Potential challenges include changes in Medicare reimbursement policies and compliance with various regulations that could negatively affect financial performance. While the company shows strong performance, including a 16% revenue growth, these risks pose substantial threats to operations. The presentation underlines the volatile environment and the need for adaptability in the face of regulatory changes and competitive pressures.
Read more →-USPH
Feb 25, 2026USPh Reports Fourth Quarter and Full Year 2025 Results
USPh has reported its financial results for the fourth quarter and full year of 2025. The announcement was made on February 25, 2026, but specific financial details were not provided in the article. The report is part of the company's ongoing communication with investors and stakeholders.
Read more →-USPH
Feb 25, 2026U.S. Physical Therapy Reports Fourth Quarter and Full Year 2025 Results
U.S. Physical Therapy, Inc. reported robust financial results for the fourth quarter and full year ended December 31, 2025, with a revenue increase of over 16% and gross profit growth exceeding 20%. The company highlighted several acquisitions and new hospital partnerships, which are anticipated to enhance patient service and value creation in the future. Operating income saw a decrease compared to the previous year, though adjusted operating income showed a significant increase of 30.3%. Overall, the financial performance and strategic initiatives signal a promising outlook for the company.
Read more →About US Physical Therapy Inc
Headquarters1300 WEST SAM HOUSTON PARKWAY SOUTH, HOUSTON, TX, 77043
BIOPHARMAWATCH ELITE PLUS
Trade the next USPH catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime